J. Soudon

In vitro activity of S 9788 on a multidrug-resistant leukemic cell line and on normal hematopoietic cells—reversal of multidrug resistance by sera from phase I-treated patients

F. Calvo, C. Lucas, M. Berlion, 2004, Cancer Chemotherapy and Pharmacology.

Comparison of in vitro exemestane activity versus other antiaromatase agents.

J. Soudon, 2000, Clinical breast cancer.

Bisbenzylisoquinolines as modulators of chloroquine resistance in Plasmodium falciparum and multidrug resistance in tumor cells

F. Calvo, P. Rasoanaivo, P. Grellier, 1996, Antimicrobial agents and chemotherapy.

Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules.

M. Piccart, A. Awada, S. Giacchetti, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

c-myc gene expression in a leukemic T-cell line bearing a t(8;14) (q24;q11) translocation.

O. Bernard, C. Larsen, D. Mathieu-Mahul, 1991, Leukemia.

Two human leukemic T cell lines with a t(8;14)(q24;q11) translocation (KE-37R and SKW3 cells) may have a common origin.

R. Berger, O. Bernard, A. Bernheim, 1988, Leukemia.